Asset Management Group, Inc. Gilead Sciences, Inc. Transaction History

Asset Management Group, Inc.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$76.01 - $86.7 $2,204 - $2,514	29 Added 0.98%	2,999 $231,000
Q1 2023 May 15, 2023	BUY	$77.31 - $88.08 $2,087 - $2,378	27 Added 0.92%	2,970 $246,000
Q4 2022 Feb 14, 2023	BUY	$62.32 - $89.47 $183,407 - $263,310	2,943 New	2,943 $252,000
Q2 2022 Aug 15, 2022	BUY	$57.72 - $65.01 $1,962 - $2,210	34 Added 0.98%	3,492 $216,000
Q1 2022 May 16, 2022	BUY	$57.92 - $72.58 $2,432 - $3,048	42 Added 1.23%	3,458 $206,000
Q4 2021 Feb 14, 2022	BUY	$64.88 - $73.64 $2,141 - $2,430	33 Added 0.98%	3,416 $248,000
Q3 2021 Nov 15, 2021	BUY	$67.69 - $73.03 $1,963 - $2,117	29 Added 0.86%	3,383 $236,000
Q2 2021 Aug 16, 2021	BUY	$63.47 - $69.35 $2,094 - $2,288	33 Added 0.99%	3,354 $231,000
Q1 2021 May 17, 2021	BUY	$60.0 - $68.46 $199,260 - $227,355	3,321 New	3,321 $215,000
Q4 2020 Feb 16, 2021	SELL	$56.65 - $64.55 $530,697 - $604,704	-9,368 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$62.1 - $78.08 $19,188 - $24,126	309 Added 3.41%	9,368 $592,000
Q2 2020 Aug 14, 2020	BUY	$72.34 - $84.0 $20,399 - $23,688	282 Added 3.21%	9,059 $697,000
Q1 2020 May 15, 2020	BUY	$62.63 - $80.22 $549,703 - $704,090	8,777 New	8,777 $656,000

1,893

1.02B

12M

9.04M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Asset Management Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Asset Management Group, Inc. with notifications on news.